Literature DB >> 2329961

Prevalence of liver disease and infection by hepatitis B, delta virus, and human immunodeficiency virus in two Spanish penitentiaries.

J A del Olmo1, F Llovet, J M Rodrigo, J Molina, L Aparisi, M A Serra, A Wassel, M A Bixquert.   

Abstract

We studied the prevalence of liver disease and the carrier state for hepatitis B (HBV), delta virus (HDV) and HIV-1 infection in two Valencian penitentiaries, one for males and the other for females. Serological results were correlated with history of intravenous drug addiction, alcohol abuse, homosexuality or prostitution (high-risk groups), and duration and number of internments. A high prevalence of increased transaminase levels (52.2%) and serological markers for HBV infection (66.5%) was observed amongst the inmates, figures being higher amongst high-risk individuals and inmates confined for more than 6 months. No signs of HDV or HIV-1 infection were found amongst the prison staff. Anti-HIV-1 positivity was observed most frequently amongst individuals combining both drug abuse and homosexuality/and prostitution.

Entities:  

Mesh:

Year:  1990        PMID: 2329961     DOI: 10.1007/bf00190149

Source DB:  PubMed          Journal:  Med Microbiol Immunol        ISSN: 0300-8584            Impact factor:   3.402


  12 in total

1.  Prevalence of delta infection in drug addicts in Valencia, Spain.

Authors:  J M Rodrigo; M A Serra; V Gimeno; J A Olmo; L Aparisi; A Escudero; A H Wassel; M Bixquert
Journal:  Prog Clin Biol Res       Date:  1987

2.  The incidence of Australia antigen and antibody in male prisoners of two Sydney penitentiaries.

Authors:  P G Watson; J R Watts; M Nelson
Journal:  Med J Aust       Date:  1973-09-01       Impact factor: 7.738

3.  Australia antigen in volunteer and paid blood donors.

Authors:  A Kliman
Journal:  N Engl J Med       Date:  1971-01-14       Impact factor: 91.245

4.  Au antigen in blood from prisoners.

Authors:  F J Muniz; H Malyska; W C Levin
Journal:  N Engl J Med       Date:  1971-03-04       Impact factor: 91.245

5.  HTLV-III antibodies in drug addicts in Spain.

Authors:  J M Rodrigo; M A Serra; E Aguilar; J A del Olmo; V Gimeno; L Aparisi
Journal:  Lancet       Date:  1985-07-20       Impact factor: 79.321

6.  Prison medical care for addicts.

Authors:  M M Glatt
Journal:  Lancet       Date:  1985-11-23       Impact factor: 79.321

7.  High frequency of HTLV-III antibodies among heterosexual intravenous drug abusers in the Austrian Tyrol.

Authors:  D Fuchs; H G Blecha; F Deinhardt; M P Dierich; F D Goebel; P Hengster; H Hinterhuber; D Schoenitzer; K Traill; H Wachter
Journal:  Lancet       Date:  1985-06-29       Impact factor: 79.321

8.  [Infection by hepatitis virus in inmates and personnel of a penal institution].

Authors:  M Bruguera; J M Barrera; J Costa; J M Sánchez Tapias; A Gelabert; G Ercilla; J Harranz; J Rodés
Journal:  Med Clin (Barc)       Date:  1985-04-20       Impact factor: 1.725

9.  Hepatitis in prisoner blood donors.

Authors:  W A Krotoski
Journal:  N Engl J Med       Date:  1972-01-20       Impact factor: 91.245

10.  Multicentre study of prevalence of HBV-associated delta infection and liver disease in drug-addicts.

Authors:  G Raimondo; A Smedile; L Gallo; A Balbo; A Ponzetto; M Rizzetto
Journal:  Lancet       Date:  1982-01-30       Impact factor: 79.321

View more
  2 in total

1.  Hepatitis C virus-host interactions: Etiopathogenesis and therapeutic strategies.

Authors:  Mohamed Hassan; Denis Selimovic; Abdelouahid El-Khattouti; Hanan Ghozlan; Youssef Haikel; Ola Abdelkader
Journal:  World J Exp Med       Date:  2012-04-20

Review 2.  Delta hepatitis: molecular biology and clinical and epidemiological features.

Authors:  L B Polish; M Gallagher; H A Fields; S C Hadler
Journal:  Clin Microbiol Rev       Date:  1993-07       Impact factor: 26.132

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.